PT2528900E - Síntese de derivados carboxamidina de pirazolina substituídos - Google Patents

Síntese de derivados carboxamidina de pirazolina substituídos Download PDF

Info

Publication number
PT2528900E
PT2528900E PT117024158T PT11702415T PT2528900E PT 2528900 E PT2528900 E PT 2528900E PT 117024158 T PT117024158 T PT 117024158T PT 11702415 T PT11702415 T PT 11702415T PT 2528900 E PT2528900 E PT 2528900E
Authority
PT
Portugal
Prior art keywords
synthesis
substituted pyrazoline
carboxamidine derivatives
pyrazoline carboxamidine
derivatives
Prior art date
Application number
PT117024158T
Other languages
English (en)
Inventor
Arnold Van Loevezijn
Josephus H M Lange
Gerrit A Barf
Arnold P Den Hartog
Original Assignee
Abbvie Bahamas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Bahamas Ltd filed Critical Abbvie Bahamas Ltd
Publication of PT2528900E publication Critical patent/PT2528900E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT117024158T 2010-01-29 2011-01-27 Síntese de derivados carboxamidina de pirazolina substituídos PT2528900E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29936310P 2010-01-29 2010-01-29
EP10152097 2010-01-29

Publications (1)

Publication Number Publication Date
PT2528900E true PT2528900E (pt) 2014-08-29

Family

ID=42244995

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117024158T PT2528900E (pt) 2010-01-29 2011-01-27 Síntese de derivados carboxamidina de pirazolina substituídos

Country Status (22)

Country Link
US (1) US9422244B2 (pt)
EP (1) EP2528900B1 (pt)
JP (1) JP5792195B2 (pt)
KR (1) KR20120129929A (pt)
CN (1) CN102725272B (pt)
AR (1) AR079935A1 (pt)
AU (1) AU2011209372B2 (pt)
CA (1) CA2787289A1 (pt)
DK (1) DK2528900T3 (pt)
ES (1) ES2485891T3 (pt)
HK (1) HK1174638A1 (pt)
HR (1) HRP20140655T1 (pt)
MX (1) MX2012008798A (pt)
PL (1) PL2528900T3 (pt)
PT (1) PT2528900E (pt)
RS (1) RS53498B1 (pt)
RU (1) RU2550694C2 (pt)
SG (1) SG182635A1 (pt)
SI (1) SI2528900T1 (pt)
SM (1) SMT201400119B (pt)
TW (1) TWI547485B (pt)
WO (1) WO2011092226A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105665148B (zh) * 2016-01-15 2018-05-04 中南大学 一种异硫氰酸酯衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156007A (en) 1974-07-12 1979-05-22 U.S. Philips Corporation Pyrazoline compounds
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
JPS608211A (ja) 1983-06-28 1985-01-17 Showa Denko Kk 農園芸用殺菌剤
JPH062742B2 (ja) * 1987-06-17 1994-01-12 三井東圧化学株式会社 新規2‐ピラゾリン類及びそれを有効成分とする脳血管障害治療剤
SI1373216T1 (en) 2001-03-22 2005-06-30 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
KR100950430B1 (ko) * 2001-09-21 2010-04-02 솔베이 파마슈티칼스 비. 브이 효력있는 cb1-길항 작용을 가지는4,5-디하이드로-1h-피라졸 유도체
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
AU2006328483A1 (en) 2005-12-20 2007-06-28 Solvay Pharmaceuticals B.V. 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TW200730500A (en) 2005-12-20 2007-08-16 Solvay Pharm Bv 4, 5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TWI428334B (zh) 2006-09-22 2014-03-01 Abbvie Bahamas Ltd 作為5-ht6拮抗劑之磺醯基吡唑及磺醯基吡唑啉的甲脒衍生物
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
AR070898A1 (es) * 2008-03-18 2010-05-12 Solvay Pharm Bv Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6
RU2374233C1 (ru) 2008-05-19 2009-11-27 Государственное образовательное учреждение высшего профессионального образования "Российский химико-технологический университет им. Д.И. Менделеева" (РХТУ им. Д.И. Менделеева) ЗАМЕЩЕННЫЕ 2-ТИОКАРБАМОИЛ-3-ФЕНИЛ-3,3а,4,5,6,7-ГЕКСАГИДРО-2Н-ИНДАЗОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ФУНГИЦИДНАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
TW201010981A (en) 2008-08-01 2010-03-16 Solvay Pharm Bv Synthesis of 3,4-diaryl-4,5-dihydro-(1H)-pyrazole-1-carboxamidine derivatives

Also Published As

Publication number Publication date
RU2550694C2 (ru) 2015-05-10
CN102725272B (zh) 2015-07-15
WO2011092226A1 (en) 2011-08-04
SG182635A1 (en) 2012-08-30
JP2013518080A (ja) 2013-05-20
JP5792195B2 (ja) 2015-10-07
MX2012008798A (es) 2012-08-17
HRP20140655T1 (hr) 2014-10-10
ES2485891T3 (es) 2014-08-14
DK2528900T3 (da) 2014-08-25
SMT201400119B (it) 2014-11-10
RU2012136831A (ru) 2014-03-10
PL2528900T3 (pl) 2014-10-31
AU2011209372B2 (en) 2015-06-04
AU2011209372A1 (en) 2012-08-30
US9422244B2 (en) 2016-08-23
SI2528900T1 (sl) 2014-09-30
CA2787289A1 (en) 2011-08-04
US20130060041A1 (en) 2013-03-07
CN102725272A (zh) 2012-10-10
WO2011092226A8 (en) 2012-09-07
TW201125852A (en) 2011-08-01
RS53498B1 (en) 2015-02-27
TWI547485B (zh) 2016-09-01
EP2528900A1 (en) 2012-12-05
KR20120129929A (ko) 2012-11-28
AR079935A1 (es) 2012-02-29
EP2528900B1 (en) 2014-06-11
HK1174638A1 (en) 2013-06-14

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
EP2510089A4 (en) SYNTHESIS OF PRAZOL COMPOUNDS
HK1159173A1 (zh) 岩藻糖化化合物的合成
PL3590340T3 (pl) Związki pośrednie do syntezy pirazoli grzybobójczych
EP2542531A4 (en) PROCESS FOR THE SYNTHESIS OF FIPRONIL
IL221170A0 (en) Processes of synthesizing dihydropyridophthalazinone derivatives
IL223300A0 (en) Pyrazole compounds as sigma receptor inhibitors
IL228604A0 (en) Synthesis of 5-azacytidine
EP2524029A4 (en) ELECTRO-AUTOTROPHE SYNTHESIS OF HIGHER ALCOHOLS
ZA201100123B (en) Bromine-facilitated synthesis of fluoro-sulfur compounds
EP2618662A4 (en) SYNTHESIS SUBSTITUTED SALICYL ALDEHYDE DERIVATIVES
IL224847B (en) Synthesis of oligoribonucleotides
EP2726458A4 (en) SYNTHESIS OF CLEISTANTHIN A AND DERIVATIVES THEREOF
PL2473549T3 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL223926A0 (en) Synthesis of cyclopentaquinazolines
IL221005A (en) Method for Synthesis of 5-Amino-1-Phenyl-3-Cyano-4-Trifluoromethyl Sulfinyl Phosphorus
HK1174638A1 (en) Synthesis of substituted pyrazoline carboxamidine derivatives
IL225708A0 (en) Methods for the synthesis of scylitol and related compounds
SI2504309T1 (sl) Sinteza acetokslacetaldehida
EP2760876A4 (en) NEW PROCESS FOR SYNTHESIS OF FUCOSE
PL2407159T3 (pl) Kompozycje farmaceutyczne olmesartanu
EP2470504A4 (en) SYNTHESIS OF PROPRIERINE HYDROCHLORIDE
EP2440059A4 (en) IMPROVED SYNTHESIS OF PICOPLATIN
GB201012036D0 (en) Synthesis of new carbohydrate derivatives
EP2773368A4 (en) COLLAGEN SYNTHESIS INHIBITION